Resistance of Schistosoma mansoni to praziquantel: Is there a problem?

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue 5, 2002, Pages 465-469

  Doenhoff, Michael J ^a   Kusel, John R ^b   Coles, Gerald C ^c   Cioli, Donato ^d  

^a BANGOR UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d Institute of Cell Biology   (Italy)

Author keywords

Chemotherapy; Drug resistance; Oxamniquine; Praziquantel; Schistosoma mansoni; Schistosomiasis

Indexed keywords

CYTOCHROME C OXIDASE; OXAMNIQUINE; PRAZIQUANTEL;

AFRICA; CONTROLLED STUDY; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; EGYPT; GENETIC IDENTIFICATION; HUMAN; IN VITRO STUDY; LABORATORY TEST; MOUSE; NONHUMAN; PARASITE ISOLATION; REVIEW; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SENEGAL; SIDE EFFECT; TABLET FORMULATION;

SCHISTOSOMA; SCHISTOSOMA MANSONI; TREMATODA;

EID: 0036758608     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90405-0     Document Type: Review

References (50)

1. Appleton, C. C. & Mbaye, A. (2001). Praziquantel-quality, dosages and markers of resistance. Parasitology Today, 17, 356-357.
2. Bennett, J. L., Day, T., Liang, F. T., Ismail, M. & Farghaly, A. (1997). The development of resistance to anthelmintics: a perspective with an emphasis on the antischistosomal drug praziquantel. Experimental Parasitology, 87, 260-267.
3. Butterworth, A. E., Sturrock, R. F., Ouma, J. H., Mbugua, G. G., Fulford, A. J. C., Kariuki, H. C. & Koech, D. (1991). Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya - effects on human infection and morbidity. Parasitology, 103, 339-355.
4. Cioli, D. (1998). Chemotherapy of schistosomiasis: an update. Parasitology Today, 14, 418-422.
5. Cioli, D. (2000). Praziquantel: is there real resistance and are there alternatives? Current Opinion in Infectious Diseases, 13, 659-663.
6. Cioli, D., Pica-Mattoccia, L. & Archer, S. (1993). Drug-resistance in schistosomes. Parasitology Today, 9, 162-166.
7. Coles, G. C. (2002a). Drug resistance or tolerance in schistosomes? Trends in Parasitology, 18, 294.
8. Coles, G. C. (in press). The sustainable use of anthelmintics in grazing animals. Veterinary Record.
9. Coles, G. C. & Kinoti, G. K. (1997). Defining resistance in Schistosoma. Parasitology Today, 13, 157-158.
10. Coles, G. C., Mutahi, W. T., Kinoti, G. K., Bruce, J. I. & Katz, N. (1987). Tolerance of Kenyan Schistosoma mansoni to oxamniquine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 782-785.
11. Correa-Oliveira, R., Caldas, I. R. & Gazzinelli, G. (2000). Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitology Today, 16, 397-399.
12. Dansio-Appiah, A. & De Vlas, S. J. (2002). The interpretation of low praziquantel cure rates in population treatment of Schistosoma mansoni infection. Trends in Parasitology, 18, 125-129.
13. Doenhoff, M. J. (1998). Is schistosomicidal chemotherapy sub-curative? Implications for drug resistance. Parasitology Today, 14, 434-435.
14. Doenhoff, M. J., Sabah, A. A. A., Fletcher, C., Webbe, G. & Bain, J. (1987). Evidence of an immune-dependent action of praziquantel on Schistosoma mansoni in mice. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 947-951.
15. Doenhoff, M. J., Kimani, G. & Cioli, D. (2000). Praziquantel and the control of schistosomiasis. Parasitology Today, 16, 364-366.
16. El-Khoby, T., Galal, N. & Fenwick, A. (1998). The USAID Government of Egypt's Schistosomiasis Research Project (SRP). Parasitology Today, 14, 92-96.
17. Fallon, P. G. & Doenhoff, M. J. (1994). Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug-specific. American Journal of Tropical Medicine and Hygiene, 51, 83-88.
18. Fallon, P. G., Sturrock, R. F., Niang, C. M. & Doenhoff, M. J. (1995). Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene, 53, 61-62.
19. Fallon, P. G., Tao, L.-F., Ismail, M. M. & Bennett, J. L. (1996). Schistosome resistance to praziquantel: fact or artifact. Parasitology Today, 12, 316-320.
20. Fallon, P. G., Mubarak, J. S., Fookes, R. E., Niang, M., Butterworth, A. E., Sturrock, R. F. & Doenhoff, M. J. (1997). Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Experimental Parasitology, 86, 29-36.
21. Geerts, S. & Gryseels, B. (2000). Drug resistance in human helminths: current situation and lessons from livestock. Clinical Microbiology Reviews, 13, 207-222.
22. Gryseels, B., Stelma, F. F., Talla, I., Van Dam, G. J., Polman, K., Sow, S., Diaw, M., Sturrock, R. F., Doehring-Schwertfeger, E., Kardorff, R., Decam, C., Niang, M. & Deelder, A. M. (1994). Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Tropical and Geographical Medicine, 46, 209-219.
23. Gryseels, B., Mbaye, A., De Vlas, S. J., Stelma, F. F., Guisse, F., Van Lieshout, L., Faye, D., Diop, M., Ly, A., Tchuem-Tchuente, L. A., Engels, D. & Polman, K. (2002). Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Tropical Medicine and International Health, 6 864-873.
24. Guisse, F., Polman, K., Stelma, F. F., Mbaye, A., Talla, I., Niang, M., Deelder, A. M., Ndir, O. & Gryseels, B. (1997). Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in northern Senegal. American Journal of Tropical Medicine and Hygiene, 56, 511-514.
25. Ismail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L.-F. & Bennett, J. L. (1996). Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. American Journal of Tropical Medicine and Hygiene, 55, 214-218.
26. Ismail, M., Botros, S., Metwally, A., William, S., Farghally, A., Tao, L.-F., Day, T. A. & Bennett, J. L. (1999). Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. American Journal of Tropical Medicine and Hygiene, 60, 932-935.
27. Katz, N., Dias, E. P., Araujo, N. & Souza, C. P. (1973). Estudo de uma cepa humana de Schistosoma mansoni resistente a agentes esquistossomicidas. Revista da Sociedade Brasileira de Medicina Tropical, 7, 381-387.
28. Katz, N., Rocha, R. S., De Souza, C. P., Coura, P., Bruce, J. I., Coles, G. C. & Kinoti, G. K. (1991). Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of 1st treatment. American Journal of Tropical Medicine and Hygiene, 44, 509-512.
29. Kohn, A. B., Anderson, P. A. V., Roberts-Misterly, J. M. & Greenberg, R. M. (2001). Schistosome calcium channel β subunits: unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel. Journal of Biological Chemistry, 276, 36873-36876.
30. Kusel, J. & Hagan, P. (1999). Praziquantel - its use, cost and possible development of resistance. Parasitology Today, 15, 352-354.
31. Liang, Y. S., Coles, G. C. & Doenhoff, M. J. (2000). Detection of praziquantel resistance in schistosomes. Tropical Medicine and International Health, 5, 72.
32. Liang, Y.-S., Coles, G. C., Doenhoff, M. J. & Southgate, V. R. (2001a). In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. International Journal for Parasitology, 31, 1227-1235.
33. Liang, Y.-S., Coles, G. C., Dai, J.-R., Zhu, Y.-C. & Doenhoff, M. J. (2001b). Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni. Annals of Tropical Medicine and Parasitology, 95, 715-723.
34. Martin, P. J., Le Jambre, L. F. & Claxton, J. H. (1981). The impact of refugia on the development of thiabendazole resistance in Haemonchus contortus. International Journal for Parasitology, 11, 35-41.
35. Mutapi, F. (2001). Heterogeneities in anti-schistosome humoral responses following chemotherapy. Trends in Parasitology, 17, 518-524.
36. Pereira, C., Fallon, P. G., Cornette, J. C., Capron, A., Doenhoff, M. J. & Pierce, R. J. (1998). Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni. Parasitology, 117, 63-73.
37. Pica-Mattoccia, L., de Souza Dias, L. C., Moroni, R. & Cioli, D. (1993). Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene. Experimental Parasitology, 77, 445-449.
38. Piquet, M., Vercruysse, J., Shaw, D. J., Diop, M. & Ly, A. (1998). Efficacy of praziquantel against Schistosoma mansoni in northern Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 90-93.
39. Polderman, A. M., Gryseels, B. & De Caluwe, P. (1988). Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 115 -116.
40. Renganathan, E. & Cioli, D. (1998). An international initiative on praziquantel use. Parasitology Today, 14, 390-391.
41. Sabah, A. A., Fletcher, C., Webbe, G. & Doenhoff, M. J. (1985). Schistosoma mansoni-reduced efficacy of chemotherapy in infected T-cell-deprived mice. Experimental Parasitology, 60, 348-354.
42. Sabah, A. A., Fletcher, C., Webbe, G. & Doenhoff, M. J. (1986). Schistosoma mansoni - chemotherapy of infections of different ages. Experimental Parasitology, 61, 294-303.
43. Stelma, F. F., Talla, A., Sow, S., Kongs, A., Niang, M., Polman, K., Deelder, A. M. & Gryseels, B. (1995). Efficacy and side-effects of praziquantel in an epidemic focus of Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene, 53, 167-170.
44. Stelma, F. F., Sall, S., Daff, B., Sow, S., Niang, M. & Gryseels, B. (1997). Oxamniquine cures Schistosoma mansoni in a focus in which cure rates with praziquantel are unusually low. Journal of Infectious Diseases, 176, 304-307.
45. Tchuem Tchenté, L. A., Southgate, V. R., Mbaye, A., Engels, D. & Gryseels, B. (2001). The efficacy of praziquantel against Schistosoma mansoni infection in Ndombo, northern Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 65-66.
46. Tsai, M.-H., Marx, K. A., Ismail, M. M. & Tao, L.-F. (2000). Randomly-amplified polymorphic DNA (RAPD) polymerase chain reaction assay for determination of Schistosoma mansoni strains sensitive or tolerant to anti-schistosomal drugs. Journal of Parasitology, 86, 146-149.
47. Van Lieshout, L., Stelma, F. F., Guissé, F., Ferreira, S. T. M. F., Polman, K., Van Dam, G. J., Diakhate, M., Sow, S., Deelder, A. & Gryseels, B. (1999). The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal. American Journal of Tropical Medicine and Hygiene, 61, 760-765.
48. Van Wyk, J. A. (2001). Refugia-overlooked as perhaps the most potent factor concerning development of anthelmintic resistance. Ondesterpoort Journal of Veterinary Research, 68, 55-67.
49. William, S., Botros, S., Ismail, M., Farghally, A., Day, T. A. & Bennett, J. L. (2001a). Praziquantel-induced tegumental damage is diminished in schistosomes derived from praziquantel-resistant infections. Parasitology, 122, 63-66.
50. William, S., Sabra, A., Ramzy, F., Mousa, M., Demerdash, Z., Bennett, J. L., Day, T. A. & Botros, S. (2001b). Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. International Journal for Parasitology, 31, 1093-1100.